Clinical Trial Update: Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated allogeneic human bone marrow-derived mesenchymal stem cells in localized prostate cancer. The trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED